New drug MT-8554 tested for safety in healthy people
NCT ID NCT02429102
First seen Jan 10, 2026 · Last updated May 16, 2026 · Updated 21 times
Summary
This early-stage study tested the safety and how the body handles a new drug called MT-8554. It involved 135 healthy adults, mostly Caucasian, aged 18 to 55 or older. Researchers monitored vital signs, heart activity, lab tests, and side effects. This study did not aim to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Investigational center
City Name, United Kingdom
Conditions
Explore the condition pages connected to this study.